StockWatch
·
Biotechnology: Laboratory Analytical Instruments
Quarterly ResultJul 29, 2026, 06:17 AM

Avantor Q2 Net Sales $1.69B; Raises FY26 Organic Revenue & EPS Guidance

AI Summary

Avantor, Inc. reported second quarter 2026 financial results, with net sales of $1,692.3 million, a 0.5% increase year-over-year, though organic sales declined by 0.4%. Net income was $38.1 million, and diluted GAAP EPS was $0.06, while adjusted EPS reached $0.21. The company exceeded its expectations for the quarter and subsequently increased its full-year 2026 organic revenue growth and adjusted EPS guidance, citing improved business performance and robust free cash flow used for debt repayment.

Key Highlights

  • Increased FY 2026 organic revenue growth guidance to -0.5% to +0.5%.
  • Raised FY 2026 adjusted EPS guidance to $0.80-$0.83.
  • Q2 2026 net sales were $1,692.3 million, a 0.5% increase (0.4% organic decline).
  • Q2 2026 net income was $38.1 million; diluted GAAP EPS was $0.06.
  • Q2 2026 adjusted EBITDA was $254.3 million; adjusted EPS was $0.21.
  • VWR Distribution & Services segment organic net sales increased by 1.7%.
  • Bioscience & Medtech Products segment organic net sales declined by 5.6%.
  • Generated $142.8 million in free cash flow, repaying $112.1 million of debt.